CHRISTY DAVIS: Open Payments
NPI 1063662419 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$43,643 in 179 payments from 30 companies in 2025. Trend: 2023 $70,891 · 2024 $25,808 · 2025 $43,643
Speaker / faculty: $31,692Travel & lodging: $7,668Food & beverage: $4,275Education: $8
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 40 | $40,565 |
| Amgen Inc. | 21 | $484 |
| Corcept Therapeutics | 11 | $341 |
| Lilly USA, LLC | 17 | $336 |
| Abbott Laboratories | 17 | $302 |
| ABBVIE INC. | 11 | $203 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $200 |
| Dexcom, Inc. | 8 | $197 |
| Novartis Pharmaceuticals Corporation | 6 | $127 |
| Tandem Diabetes Care, Inc. | 7 | $127 |
Products named: Wegovy, EVENITY, Korlym, FREESTYLE LIBRE 3, UBRELVY, Dexcom G6 Transmitter, MOUNJARO, ZEPBOUND.
Industry payments across MS — which companies pay providers there.
